Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19805,805,0.97 [0.85-1.11],0.6932701592761616
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19184,235,1.17 [0.92-1.48],0.1959937790261541
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21963,136,0.99 [0.72-1.36],0.9585236341853972
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14816,801,1.13 [0.98-1.29],0.087475336952911
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21923,96,1.13 [0.78-1.63],0.5094661256393167
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19879,88,1.06 [0.72-1.56],0.7710758138379497
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22949,95,1.14 [0.79-1.63],0.489852391947746
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22961,65,0.98 [0.62-1.55],0.924157631006599
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19467,53,1.49 [0.95-2.33],0.0789338423139076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21980,115,0.90 [0.63-1.28],0.5576137744129555
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21947,82,0.89 [0.59-1.36],0.5991596189424038
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23034,57,1.13 [0.71-1.80],0.6103206370699834
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23059,62,0.86 [0.54-1.38],0.5384977544275165
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23052,55,0.90 [0.55-1.48],0.6839882508762005
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Mycoses,22724,42,1.16 [0.68-1.98],0.5783414291396594
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21806,386,1.03 [0.85-1.24],0.7852856499063108
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21570,150,1.13 [0.84-1.50],0.4202844614506721
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21681,261,0.95 [0.75-1.19],0.6529617106622954
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",18025,79,0.97 [0.63-1.48],0.8761564419518162
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",17994,48,1.05 [0.62-1.78],0.8644592137082846
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18204,258,1.01 [0.80-1.27],0.9420178724217932
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18213,267,1.02 [0.81-1.28],0.8693289675937238
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18178,232,0.91 [0.71-1.17],0.4751452016821182
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",17999,53,1.04 [0.63-1.71],0.8903383523426567
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20469,545,1.21 [1.04-1.41],0.0153828175170427
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21578,368,0.93 [0.77-1.13],0.489140832540668
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22467,123,0.93 [0.67-1.30],0.6701798440161206
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23094,130,0.93 [0.68-1.29],0.6839544470135819
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Rectum,22770,73,1.03 [0.68-1.57],0.8787946367124164
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23110,64,1.31 [0.86-2.00],0.2066917920457003
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Stomach,23156,46,1.21 [0.73-2.02],0.4627055687767034
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,22839,309,0.98 [0.79-1.21],0.8384313527466111
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23121,106,0.79 [0.54-1.14],0.2058938149281317
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23129,73,0.89 [0.57-1.37],0.5832184375047409
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23078,33,0.88 [0.46-1.68],0.6916402787895539
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma, any site",23081,33,0.88 [0.46-1.68],0.6916991249169858
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi,23007,127,1.15 [0.84-1.56],0.3841516545949266
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23135,53,1.24 [0.78-1.98],0.3643767525896446
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Other benign neoplasms of skin,23043,135,0.84 [0.61-1.16],0.2797735715461976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21988,121,1.37 [1.01-1.85],0.0403032625519622
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21617,252,1.12 [0.89-1.40],0.344220568981409
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21617,252,1.12 [0.89-1.40],0.344220568981409
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19430,494,1.13 [0.97-1.33],0.1266252307197564
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22652,38,0.97 [0.87-1.08],0.605659560539799
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22906,60,1.09 [0.69-1.74],0.7033239092220287
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18133,1411,1.08 [0.98-1.20],0.1290912654859489
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22452,178,1.15 [0.89-1.50],0.2898439744633022
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20457,150,1.22 [0.92-1.61],0.1759867295708963
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21827,159,0.85 [0.63-1.15],0.2979529252143573
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20442,135,1.14 [0.84-1.55],0.3915698760580195
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,20985,678,1.05 [0.91-1.22],0.5261358694130569
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,20960,653,1.03 [0.89-1.20],0.6583062854485533
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21450,171,0.85 [0.61-1.18],0.3220404685481183
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21450,170,0.86 [0.62-1.19],0.3549005910135618
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17981,1259,1.09 [0.98-1.22],0.1187630481291681
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16903,181,1.02 [0.77-1.35],0.8902406990322038
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,17878,1156,1.11 [0.99-1.24],0.0827057819026144
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16771,49,1.25 [0.76-2.05],0.3761600939455124
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16820,98,1.05 [0.73-1.52],0.7776773239379717
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,19637,667,1.12 [0.97-1.30],0.1112337823681825
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19301,331,1.06 [0.87-1.30],0.5556213702701953
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22604,255,1.04 [0.83-1.31],0.7316456449929443
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22691,195,1.14 [0.88-1.47],0.3377544434701115
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21104,76,0.98 [0.65-1.48],0.9203769543143304
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23015,76,0.96 [0.63-1.47],0.8678563437197032
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19046,76,0.97 [0.64-1.47],0.8819938974221841
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Alcohol dependence,21140,112,0.96 [0.68-1.36],0.8086745387213082
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,21131,80,1.39 [0.96-2.01],0.0794612215007048
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19033,63,0.87 [0.54-1.38],0.5438453779065204
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19232,262,1.18 [0.95-1.46],0.1387064352250235
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Depression,21998,222,1.14 [0.90-1.45],0.2631701513801373
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Depression or dysthymia,18943,189,1.11 [0.86-1.43],0.4278918889761421
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19071,101,1.13 [0.80-1.60],0.4915975276794807
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Other anxiety disorders,22182,53,1.13 [0.70-1.84],0.613001757006236
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,19613,1282,1.05 [0.95-1.17],0.3420113148939334
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17655,81,1.12 [0.75-1.66],0.5775061145905651
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23060,58,1.07 [0.67-1.70],0.7832650434779473
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21855,528,1.05 [0.90-1.23],0.5446863467013252
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Epilepsy,21484,157,0.81 [0.60-1.10],0.1777892911478594
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Migraine,21360,33,1.01 [0.54-1.92],0.966640880546657
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22997,27,0.97 [0.47-1.97],0.9220706395027662
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22214,97,0.84 [0.57-1.23],0.3663782395643022
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other sleep disorders,21561,234,1.32 [1.05-1.66],0.0180310047486081
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Sleep apnoea,22443,184,1.23 [0.95-1.60],0.1224713395481679
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22241,463,1.11 [0.94-1.31],0.239976958423832
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21895,117,1.16 [0.84-1.60],0.369168722556216
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21994,216,1.06 [0.83-1.36],0.6401776807233963
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22819,86,0.86 [0.58-1.29],0.4765516975770992
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hemiplegia,22788,55,0.89 [0.53-1.47],0.6417208612410946
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other neurological diseases,22664,114,0.98 [0.70-1.39],0.9256317211042392
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22580,300,0.90 [0.72-1.11],0.3216918584578188
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22451,171,0.92 [0.69-1.23],0.5851130148784247
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22355,75,0.78 [0.51-1.21],0.271184341174824
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22384,104,0.89 [0.62-1.29],0.5398847647963497
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22328,48,0.86 [0.50-1.49],0.5977730631913964
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20233,138,1.23 [0.91-1.65],0.1817776129177692
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20471,376,1.14 [0.95-1.37],0.167623175450839
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22203,246,1.32 [1.06-1.64],0.0128087896238122
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22759,71,1.52 [1.05-2.22],0.0282169979034805
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2519,71,1.51 [1.00-2.29],0.0479956249847547
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20311,71,1.53 [1.05-2.22],0.0270199770950013
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22514,93,0.93 [0.63-1.37],0.713283170415304
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22470,49,1.16 [0.70-1.91],0.5708869100380474
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22618,75,1.13 [0.75-1.69],0.5596529427074829
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22641,90,0.98 [0.67-1.44],0.9103341954886286
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23068,133,1.04 [0.76-1.42],0.8166551032556459
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22244,98,1.14 [0.80-1.62],0.4640808126239517
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15647,3671,0.99 [0.91-1.07],0.769869908064234
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22479,61,0.89 [0.55-1.43],0.6199202604212743
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16512,2407,1.03 [0.95-1.13],0.4450297322602631
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,16557,2452,1.04 [0.95-1.13],0.3902847430260333
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14213,108,1.09 [0.77-1.55],0.6206259009029507
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20494,1637,0.94 [0.86-1.04],0.2581568022116804
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,19774,917,0.90 [0.79-1.03],0.1160848562850503
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21750,327,1.01 [0.83-1.24],0.8956117109590982
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22136,713,1.00 [0.87-1.15],0.975712657141626
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22961,158,0.92 [0.69-1.24],0.5993244659374406
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19342,485,0.97 [0.82-1.15],0.7254494615345876
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20230,1396,0.96 [0.86-1.06],0.3983413384293948
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22304,117,1.26 [0.92-1.73],0.1550268494546767
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22406,237,1.12 [0.89-1.41],0.3345714556724659
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22270,83,0.95 [0.63-1.43],0.8086618888569073
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22272,85,0.96 [0.64-1.43],0.8462069057522915
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14184,79,0.98 [0.65-1.47],0.9116670326375322
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18116,78,1.39 [0.95-2.04],0.093067114688062
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Conduction disorders,18201,163,0.75 [0.55-1.02],0.0626169064196071
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11455,131,0.88 [0.63-1.23],0.4420165889110078
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11911,587,0.82 [0.69-0.97],0.0206122192451897
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arrhythmias,18120,82,0.78 [0.51-1.19],0.2457875469679897
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18161,123,0.67 [0.47-0.96],0.0276820748943038
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21883,306,0.98 [0.79-1.21],0.8307384289600341
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22149,181,1.35 [1.05-1.73],0.0195179251958553
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22175,164,1.42 [1.09-1.83],0.0083509561750925
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22262,145,1.47 [1.12-1.93],0.0051991524190927
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21797,84,0.76 [0.50-1.16],0.2101848526307953
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21854,141,0.98 [0.72-1.35],0.9152851748912676
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21862,148,1.10 [0.82-1.48],0.5118130797634997
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21846,132,1.15 [0.85-1.56],0.3738789239518244
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22927,125,1.26 [0.92-1.71],0.1446667655740106
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Varicose veins,22041,327,0.83 [0.67-1.03],0.0873186294599166
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,21904,81,0.73 [0.48-1.13],0.1646055515065573
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18049,1950,1.05 [0.96-1.14],0.2895555015400326
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22988,86,1.25 [0.87-1.81],0.2292272763297631
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,21092,245,1.17 [0.94-1.47],0.1667691710664982
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",21055,208,1.14 [0.89-1.46],0.293576278031247
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22214,269,1.13 [0.91-1.41],0.2654657746168319
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22211,266,1.13 [0.90-1.41],0.2903593765464004
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22330,640,0.91 [0.78-1.06],0.2112876088268396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic sinusitis,21761,71,0.73 [0.46-1.15],0.1766289596436818
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Nasal polyp,21857,167,1.01 [0.76-1.33],0.965335038585728
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22105,415,0.90 [0.75-1.08],0.2412437282467795
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Deviated nasal septum,21909,219,0.83 [0.64-1.07],0.1474290384552845
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10041,60,0.90 [0.56-1.45],0.6623851225579019
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20699,820,1.04 [0.92-1.19],0.5372264923882308
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Early onset COPD,21879,190,0.91 [0.69-1.20],0.5104812592986181
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21909,220,0.99 [0.77-1.28],0.9410542674373966
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21909,220,0.99 [0.77-1.28],0.9410542674373966
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21787,638,1.03 [0.90-1.20],0.644667577393993
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Asthma,15740,638,1.06 [0.92-1.23],0.413877246813589
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15404,638,1.06 [0.91-1.22],0.4608066173969867
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15730,628,1.05 [0.91-1.22],0.4810052604130878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22742,95,1.23 [0.86-1.75],0.2579308677570288
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,22021,75,1.34 [0.91-1.97],0.1328286703529565
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22823,75,1.35 [0.92-1.98],0.1288723737423339
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22014,68,1.26 [0.83-1.91],0.2695858039703487
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,20908,131,0.91 [0.66-1.26],0.590077556953724
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,21052,275,1.00 [0.80-1.24],0.974178101393913
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21822,122,1.20 [0.88-1.64],0.253583429624328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15423,5445,1.01 [0.95-1.08],0.670519230989816
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22683,352,0.95 [0.78-1.16],0.62296719010887
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23127,76,1.03 [0.68-1.55],0.8906513859511644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impacted teeth,23130,73,1.03 [0.68-1.56],0.9001117603626546
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Dental caries,22439,108,1.28 [0.93-1.77],0.1281881359202141
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22410,79,0.86 [0.56-1.31],0.4721104340863148
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23118,84,1.00 [0.67-1.48],0.9865672759055708
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22408,77,0.81 [0.53-1.25],0.3369694866261861
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22183,75,1.22 [0.83-1.81],0.3151185079554738
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23062,54,1.07 [0.66-1.73],0.7756865260757964
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17726,313,1.18 [0.97-1.45],0.0940534623512679
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19361,1948,0.98 [0.89-1.06],0.5763147792953316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophagitis,17798,385,0.97 [0.80-1.17],0.73059807444749
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18040,627,0.88 [0.76-1.03],0.1087696344014732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17483,70,0.86 [0.55-1.35],0.515358578491828
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17679,266,0.97 [0.77-1.21],0.77490091193653
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17487,74,0.97 [0.63-1.48],0.8704489168933194
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastric ulcer,17568,155,1.00 [0.75-1.35],0.9809379139251218
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Duodenal ulcer,17578,165,1.37 [1.06-1.77],0.0159612185402406
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22968,113,1.48 [1.10-2.01],0.0105498839218154
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic gastritis,17527,114,0.76 [0.53-1.09],0.1350828606245804
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18182,769,0.95 [0.83-1.09],0.5006080848708883
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of appendix,23005,101,1.04 [0.73-1.48],0.8482750826640904
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Functional dyspepsia,17696,283,1.04 [0.84-1.29],0.7171277105337509
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17569,156,0.76 [0.56-1.04],0.083281816196459
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22960,164,0.85 [0.64-1.15],0.2922513623905628
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute appendicitis,22987,83,1.00 [0.67-1.48],0.986965945452442
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Hernia,19748,1988,1.04 [0.96-1.13],0.360020611529402
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Inguinal hernia,18853,1093,1.01 [0.90-1.13],0.8318608420627874
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Umbilical hernia,17936,176,1.06 [0.81-1.39],0.6643416155087173
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ventral hernia,17853,93,1.01 [0.69-1.46],0.9742828984633476
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18503,743,1.09 [0.96-1.25],0.1894585325883354
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22317,582,1.00 [0.86-1.17],0.9922308499513932
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestines,17863,1762,0.97 [0.89-1.07],0.5717355318366981
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22828,53,1.33 [0.84-2.09],0.219221170927036
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23085,69,1.34 [0.90-1.99],0.1531574040359516
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn disease,21804,69,1.34 [0.90-2.01],0.146949940109261
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21789,54,1.15 [0.72-1.85],0.5582288163141926
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23030,140,0.85 [0.62-1.16],0.3037633716184704
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcerative colitis,21875,140,0.85 [0.62-1.17],0.3150934990300196
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21861,126,0.90 [0.65-1.26],0.5481389995663347
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22172,437,1.02 [0.85-1.21],0.8424243602805476
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22169,434,1.02 [0.86-1.22],0.8050776323322586
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16189,88,1.06 [0.72-1.55],0.7850461785120466
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal stricture,22708,88,1.07 [0.73-1.56],0.7419552330039312
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16162,61,1.26 [0.81-1.96],0.3118293798047716
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16619,518,0.97 [0.82-1.14],0.7057773255494013
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16186,85,0.97 [0.65-1.45],0.893043008915641
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16275,174,1.07 [0.82-1.41],0.6126929726027807
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Constipation,21627,158,1.05 [0.79-1.40],0.7323059366296416
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22779,50,1.25 [0.78-2.02],0.3522127223060808
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16257,156,0.82 [0.61-1.11],0.2052857958039542
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16194,93,1.23 [0.86-1.76],0.2630656129190559
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,16946,845,0.98 [0.86-1.11],0.7239550851357535
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestine,16404,303,0.97 [0.78-1.21],0.7980243025262646
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22769,40,1.24 [0.73-2.12],0.4248687277288618
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of liver,22340,137,0.82 [0.59-1.14],0.240401800874365
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of liver,22284,81,0.73 [0.47-1.13],0.1560511490722041
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22046,361,1.14 [0.94-1.37],0.1825990654249545
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholelithiasis,21949,264,1.20 [0.97-1.49],0.095745892409661
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholecystitis,21749,64,1.07 [0.68-1.67],0.7675036849943067
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21718,33,1.68 [1.01-2.81],0.0465244074562504
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis,21754,69,0.98 [0.63-1.53],0.9461420474385084
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),22972,69,0.98 [0.63-1.52],0.9170080127126796
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21799,306,1.03 [0.83-1.26],0.8167926456913076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21528,35,0.84 [0.44-1.59],0.5928319924600038
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Coeliac disease,21519,26,0.74 [0.35-1.57],0.431799260385892
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21551,58,1.00 [0.62-1.61],0.9922921088280702
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21712,219,1.03 [0.81-1.32],0.7916545170397955
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,GI-bleeding,21708,215,1.03 [0.80-1.32],0.804225257205612
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20076,1454,0.93 [0.85-1.03],0.18934418270912
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22712,91,0.88 [0.59-1.30],0.5153448741285949
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22775,439,0.93 [0.78-1.12],0.4529945745482475
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,21577,446,0.91 [0.76-1.08],0.2709159765383256
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22176,460,0.89 [0.75-1.06],0.1851682144338169
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21822,106,0.80 [0.55-1.16],0.2409629640490493
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22013,297,0.91 [0.73-1.13],0.3923493013389423
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22883,88,0.95 [0.64-1.40],0.7842844400264063
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22869,74,1.04 [0.69-1.59],0.8432641397248719
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22849,54,1.05 [0.65-1.71],0.8370596903402695
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22836,57,nan [nan-nan],
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22834,55,nan [nan-nan],
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22390,54,0.84 [0.51-1.39],0.501482688618808
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22693,357,0.96 [0.79-1.17],0.686808746931124
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21209,78,0.75 [0.48-1.15],0.1879904672159003
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21176,45,0.62 [0.34-1.11],0.1077094311895351
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21171,40,0.62 [0.33-1.17],0.1395217654591914
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21309,178,1.01 [0.77-1.33],0.9222723777574936
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21287,156,0.93 [0.69-1.25],0.6306792661292191
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17088,3461,1.02 [0.95-1.09],0.598232834066464
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18536,2036,1.02 [0.94-1.11],0.6180248659199701
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20953,1054,1.02 [0.91-1.15],0.7235863758465868
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16588,88,1.41 [1.00-2.00],0.051051917930398
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16895,395,1.14 [0.95-1.37],0.1472661465801101
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22899,85,1.46 [1.03-2.07],0.0344683696933806
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22903,75,1.62 [1.14-2.31],0.0075044951024913
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17538,1038,0.97 [0.86-1.09],0.5595202665182453
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19903,1038,0.95 [0.85-1.08],0.4461621476028502
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16622,122,1.04 [0.75-1.44],0.827479683353699
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22223,118,1.06 [0.76-1.48],0.7452051047816831
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16657,157,1.05 [0.79-1.40],0.723790800769722
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16554,54,0.75 [0.45-1.26],0.2742999010762547
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16745,245,0.95 [0.75-1.20],0.657754147772021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23026,117,0.92 [0.65-1.30],0.6518485559446977
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17060,560,1.02 [0.87-1.20],0.7839172546056983
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16796,296,0.85 [0.68-1.06],0.1519906628429552
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17624,1124,1.00 [0.89-1.11],0.9385298645525844
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16523,23,0.64 [0.28-1.47],0.29453100726548
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16545,45,0.95 [0.55-1.64],0.858073004515276
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16529,29,1.36 [0.73-2.51],0.330263660156471
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16514,14,0.66 [0.24-1.84],0.4253820751370096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17081,581,1.01 [0.87-1.17],0.918489287267322
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17007,507,1.03 [0.88-1.21],0.7074567875490054
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18691,252,0.92 [0.73-1.17],0.5119189879299042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22865,35,1.20 [0.67-2.15],0.5439995318142646
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22847,17,0.52 [0.19-1.40],0.1948209321192213
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20242,44,0.94 [0.54-1.66],0.8441717980037674
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20469,271,0.95 [0.76-1.19],0.6444383818168343
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20994,796,1.01 [0.89-1.16],0.8314622696037813
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20351,153,1.04 [0.78-1.40],0.7783282497491184
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20288,90,0.84 [0.56-1.26],0.4008191580642136
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20818,620,1.07 [0.93-1.24],0.3399745705228342
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20247,49,0.93 [0.55-1.57],0.7807437629842038
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20416,218,1.09 [0.86-1.39],0.4760105403769681
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20292,94,1.01 [0.69-1.46],0.964152740492208
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20260,62,0.76 [0.46-1.23],0.262715511981702
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20311,113,1.09 [0.78-1.53],0.6173824791435845
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20247,49,1.09 [0.65-1.81],0.7433729859611393
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20447,249,1.12 [0.89-1.41],0.3263904300774735
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20133,234,1.08 [0.85-1.36],0.5383632340067793
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19962,63,1.31 [0.85-2.02],0.2187721345169906
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19961,62,1.26 [0.82-1.95],0.2926824320323403
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19959,60,1.00 [0.63-1.60],0.9871266403753948
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19959,60,1.31 [0.85-2.02],0.2205282688118259
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20068,169,1.17 [0.90-1.54],0.2437288723691644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20057,158,1.13 [0.85-1.50],0.3906709164686309
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20142,243,1.01 [0.79-1.27],0.961240302176122
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19947,48,0.91 [0.53-1.55],0.7244468579215626
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19985,86,0.90 [0.60-1.36],0.6293132882623321
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20009,110,0.92 [0.64-1.31],0.6455464414969379
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19941,42,0.60 [0.32-1.10],0.0994328456330339
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20239,340,0.87 [0.71-1.07],0.1976724401088463
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20042,143,0.90 [0.66-1.23],0.5130564198121088
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20079,180,0.87 [0.66-1.16],0.3399039339396545
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22149,101,1.11 [0.78-1.58],0.5516314288938489
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22334,286,1.14 [0.93-1.41],0.2113060822733741
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22105,57,1.01 [0.63-1.63],0.9576165923929846
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22098,50,1.31 [0.81-2.11],0.2706319589083314
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22134,86,1.11 [0.76-1.62],0.6061900474748405
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17739,2315,1.07 [0.99-1.16],0.1085898055710433
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19935,1257,1.01 [0.91-1.12],0.8628320418471658
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20426,304,1.06 [0.86-1.31],0.5589691466417589
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20214,92,0.73 [0.49-1.10],0.134163889027608
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,20452,72,1.39 [0.95-2.04],0.0887068681904802
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,20471,91,1.10 [0.76-1.61],0.6085805340520241
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20473,93,0.96 [0.66-1.42],0.8510464348896053
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22674,350,1.10 [0.91-1.33],0.3492418022162629
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22627,76,1.30 [0.88-1.92],0.1955244354718316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22571,247,1.07 [0.85-1.35],0.5520260311769035
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22456,132,1.22 [0.91-1.64],0.1918577242969875
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,20975,805,1.11 [0.98-1.26],0.1148412897777967
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cystitis,20223,53,0.81 [0.48-1.37],0.4227433580817356
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20242,72,1.41 [0.95-2.09],0.0858361372146002
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20539,369,1.20 [1.00-1.44],0.0529447844756535
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20306,136,1.00 [0.73-1.37],0.9823089709815304
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20523,353,1.08 [0.89-1.31],0.4152992200191647
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19231,553,1.08 [0.92-1.27],0.3267131804509517
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18782,104,1.06 [0.75-1.51],0.7275520201678571
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydrocele,18777,99,0.99 [0.69-1.43],0.9741213992501594
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18842,164,1.14 [0.87-1.51],0.3373626520719645
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18839,161,1.05 [0.79-1.40],0.7252745216246734
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18891,213,0.72 [0.55-0.94],0.0147201933271969
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22650,76,1.08 [0.72-1.63],0.7023057978067513
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21010,531,1.01 [0.86-1.19],0.8814737979956909
